China's Sinovac Biotech gets govt approval for more bird flu vaccine trials |
|
|
|
Published
:
Thu, 10 May 2007 11:04
|
BEIJING (XFN-ASIA) - Sinovac Biotech Ltd said China's State Food and Drug Administration has granted it approval to begin the Phase II clinical trial of Panflu, a human use vaccine against the H5N1 bird flu virus.The vaccine was jointly developed with China's Center for Disease Control, the company said in a statement, adding that two versions of the vaccine have been approved for clinical trials.'We are developing Panflu to vaccinate humans against H5N1 given the significant concern that it may evolve into a virus capable of human-to-human transmission,' said company president and CEO Yin Weidong.sean.mangieri@xfn.com
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
FDA approves first bird flu vaccine 